AMBEV S.A. current report, Q3 FY2018

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the period from August 1, 2018, to August 31, 2018. The report was filed on September 10, 2018. The document serves as a disclosure of securities and derivatives transactions involving the company's Board of Directors, Management, and related persons, in compliance with Article 11 of CVM Instruction # 358/2002.

Key Financial Metrics

The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory report on insider trading activity and holdings.

Material Changes in Holdings

According to the consolidated forms, there were no changes in the quantity of securities or derivatives held by the reported groups during the period. Initial balances matched final balances for all categories:

  • Board of Directors: Held 6,097,350 Common Shares (0.0388%) and 368,949 ADRs (0.0023%). No transactions occurred.
  • Management: Held 31,409,798 Common Shares (0.1998%), 34,385 ADRs (0.0002%), 190,000 Securities Lending positions, and various Put and Call Options. No transactions occurred.
  • Other Management (Excluding Board): Held 7,225 Common Shares (0.0000%). No transactions occurred.

Outlook, Risks, and Unusual Items

The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The only notable items are the specific derivative positions held by Management, including:

  • Four Put Options (OPVABEV series) with maturities ranging from March 2019 to August 2019.
  • Four Call Options (OPCABEV series) with maturities ranging from November 2018 to February 2019.

Investor Verification Checklist

  • Verify that the lack of transactions reported for August 2018 aligns with the company's broader insider trading policy and historical patterns.
  • Confirm the specific strike prices and terms of the Put and Call options held by Management, as only maturity dates are listed in this summary.
  • Review the company's Form 20-F or quarterly earnings releases for actual financial performance metrics, as this Form 6-K does not contain them.